Plain-English translation of NCT06450691 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying amyotrophic lateral sclerosis (ALS), a disease that affects nerve cells controlling movement, by taking small skin samples from patients and converting them into special cells in the laboratory. The goal is to understand why ALS develops differently in different people—whether it runs in families, starts at a young age, or appears randomly—so they can better understand the disease and potentially develop new treatments.
ALS is a serious disease that progressively weakens muscles, but scientists still don't fully understand why it develops or why it affects people differently. By studying skin cells from patients and people who carry ALS-causing genetic mutations but haven't yet shown symptoms, researchers hope to uncover the biological differences between disease types and find new paths to treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a small skin biopsy (a tiny sample removed under local anesthesia) and blood work done at your first visit. If you have ALS, you'll return for follow-up samples about one year later. If you carry an ALS genetic mutation but have no symptoms, follow-up samples will be collected about three years later. The skin cells collected will then be grown in the laboratory and studied to help researchers understand how ALS develops.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France